Green Molecular, a spin-out of the University of Valencia, licences its pharma tech to cosmetics firm ChromaDex.

US-based ChromaDex has announced a licensing agreement with biotech Green Molecular, a spin-out of Spain’s University of Valencia. The natural products firm is building a portfolio of patents relating to pterostilbene, a product used in skincare and developed by Green Molecular. It is the eighth patent ChromaDex has acquired for pterostilbene, and the second for…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.